You Position: Home > Paper

Octreotide acetate long-acting release in treatment of pancreatic neuroendocrine tumors

( views:35, downloads:8 )
Author:
No author available
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
13
DOI:
10.3760/cma.j.issn.0366-6999.2009.13.020
Key Word:
pancreatic neuroendocrine tumours;glucagonoma;gastrinoma;octreotide acetate

Abstract: @@ Pancreatic neuroendocrine tumours are uncommon neoplasms of the pancreas, accounting for around 2% of all primary pancreatic tumors,1 This specific group of tumours includes insulinoma, gastrinoma, glucagonoma,VIPoma, somatostatinoma and others.2 They may cause a clinical syndrome due to hormone overproduction. These tumours tend to be less aggressive than pancreatic adenocarcinoma, however, more than 50% of them have metastasized to the liver at the time of diagnosis.3 Under this circumstance, surgery is impossible to resect all metastases. Thus other various medical measures have been explored in the treatment of these tumors.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn